Enzymotec Ltd.'s ROA from the fourth quarter of 2016 to the fourth quarter of 2015 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Enzymotec Ltd.'s ROA in the fourth quarter of 2016?
Enzymotec Ltd. recorded a cumulative net loss of $-3 million during 12 months ending in the fourth quarter of 2016, resulting in a negative return on assets (ROA) of -2.04%.

However, within the Healthcare sector 207 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2016 from to 3349.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Dec 31 2016) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2015) IV. Quarter
Y / Y Total Assets Change	0.58 %	-2.02 %	-2.02 %	-2.02 %	52.98 %
Y / Y Net Income Change	-	-	-	-	-14.74 %
Net Income (TTM) in million	-3	7	7	7	7
Return On Assets (TTM)	-2.04 %	4.68 %	4.66 %	4.63 %	4.61 %
ENZY's Total Ranking	# 3349	#	#	#	# 1483
Total Assets (TTM) in million	134	146	146	146	133
Seq. Total Assets Change	-8.1 %	0 %	0 %	9.44 %	-10.47 %
Seq. Net Income Change	-	-	-	-	-

ENZY's 5 Years Annual ROA >> Back to ENZY Management Effectiveness >> Compare ENZY ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 11
Sector	# 208
Overall	# 2982

Return On Assets Statistics
High	Average	Low
5.67 %	2.72 %	-1.99 %
(Dec 31 2014)		(Dec 31 2016)

Financial Statements
Enzymotec Ltd.'s Assets	$ 134 million	ENZY's Balance sheet
Enzymotec Ltd.'s Income	$ -3 million	Quarterly ENZY's Income Statement
ENZY's Income by Division		See ENZY's Income by Division

Annual Return On Assets	(Dec 31 2016) FY 2016	(Dec 31 2015) FY 2015	(Dec 31 2014) FY 2014	(Dec 31 2011) FY 2013	FY
Y / Y Total Assets Change	0.67 %	24.36 %	-10.04 %	-	-
Total Assets in million	134	133	107	119	0
Y / Y Net Income Change	-	-14.74 %	-	-	-
Net Income in million	-3	7	8	-1	0
Annual Return On Assets	-2.18 %	5.02 %	7.32 %	-0.73 %	-

ENZY's 5 Years Annual ROA >> Back to ENZY Management Effectiveness >> Compare ENZY ROA to its Competitors

More Return On Assets Ratios
ENZY's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ENZY's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ENZY's Competitors
Subscribers only: Roa for Enzymotec Ltd.'s Suppliers
Subscribers only: Return On Assets for ENZY's Customers

You may also want to know
ENZY's Roi	ENZY's Inventory Turnover Ratio	ENZY's Growth Rates	ENZY's Dividend Comparisons
	ENZY's Profitability Ratios	ENZY's Asset Turnover Ratio	ENZY's Dividend Growth
ENZY's Roe	ENZY's Valuation Ratios	ENZY's Financial Strength Ratios	ENZY's Dividend Payout Ratio

Companies with similar Return On Assets at Dec 31 2016, within Healthcare Sector

ROA

Date modified: 2026-09-02T18:56:07+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.